Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lublin, F. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lublin, F. D.
NEUROLOGY 1996;46:907-911
© 1996 American Academy of Neurology

Defining the clinical course of multiple sclerosis

Results of an international survey

Fred D. Lublin, MD, Stephen C. Reingold, PhD and National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis*

*See page 910 for Committee members.
From the Department of Neurology (Dr. Lublin), Jefferson Medical College, Philadelphia, PA; and the Research and Medical Programs Department (Dr. Reingold), National Multiple Sclerosis Society (USA), New York, NY.
Received August 9, 1995. Accepted in final form August 18, 1995.
Address correspondence and reprint requests to Dr Lublin, Department of Neurology, Jefferson Medical College, Philadelphia, PA.

Standardization of terminology used to describe the pattern and course of MS is essential for mutual understanding between clinicians and investigators.It is particularly important in design of, and recruitment for, clinical trials statistically powered for expected outcomes for given patient populations with narrowly defined entry criteria. For agents that prove safe and effective for MS, knowledge of the patient populations in definitive clinical trials assists clinicians in determining who may ultimately benefit from use of the medication. An international survey of clinicians involved with MS revealed areas of consensus about some terms classically used to describe types of the disease and other areas for which there was lack of consensus. In this report, we provide a summary of the survey results and propose standardized definitions for the most common clinical courses of patients with MS.

NEUROLOGY 1996;46: 907-911




This article has been cited by other articles:


Home page
Mult SclerHome page
C Iarlori, D Gambi, A Lugaresi, A Patruno, M Felaco, M Salvatore, L Speranza, and M Reale
Reduction of free radicals in multiple sclerosis: effect of glatiramer acetate (Copaxone(R))
Multiple Sclerosis, July 1, 2008; 14(6): 739 - 748.
[Abstract] [PDF]


Home page
Mult SclerHome page
J Kraus, K Voigt, A. Schuller, M Scholz, K. Kim, M Schilling, W. Schabitz, P Oschmann, and B Engelhardt
Interferon-{beta} stabilizes barrier characteristics of the blood-brain barrier in four different species in vitro
Multiple Sclerosis, July 1, 2008; 14(6): 843 - 852.
[Abstract] [PDF]


Home page
Mult SclerHome page
M Koch, J De Keyser, and H Tremlett
Timing of birth and disease progression in multiple sclerosis
Multiple Sclerosis, July 1, 2008; 14(6): 793 - 798.
[Abstract] [PDF]


Home page
BrainHome page
F. Tecchio, G. Zito, F. Zappasodi, M. L. Dell' Acqua, D. Landi, D. Nardo, D. Lupoi, P. M. Rossini, and M. M. Filippi
Intra-cortical connectivity in multiple sclerosis: a neurophysiological approach
Brain, July 1, 2008; 131(7): 1783 - 1792.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. F. Lucchinetti, R. H. Gavrilova, I. Metz, J. E. Parisi, B. W. Scheithauer, S. Weigand, K. Thomsen, J. Mandrekar, A. Altintas, B. J. Erickson, et al.
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis
Brain, July 1, 2008; 131(7): 1759 - 1775.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
B. J. Williams, H. J. Skinner, and B. L. Maria
Increased Intracranial Pressure in a Case of Pediatric Multiple Sclerosis
J Child Neurol, June 1, 2008; 23(6): 699 - 702.
[Abstract] [PDF]


Home page
Mult SclerHome page
A. Hebb, C. Moore, V Bhan, T Campbell, J. Fisk, H. Robertson, M Thorne, E Lacasse, M Holcik, J Gillard, et al.
Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination
Multiple Sclerosis, June 1, 2008; 14(5): 577 - 594.
[Abstract] [PDF]


Home page
Mult SclerHome page
S Minden, D Hoaglin, S Jureidini, L Hadden, D Frankel, Y Komatsuzaki, and J Outley
Disease-modifying agents in the Sonya Slifka Longitudinal Multiple Sclerosis Study
Multiple Sclerosis, June 1, 2008; 14(5): 640 - 655.
[Abstract] [PDF]


Home page
Mult SclerHome page
M. Melcon, L Gold, A Carra, F Caceres, J Correale, E Cristiano, N Fernandez Liguori, O Garcea, G Luetic, M Kremenchutzky, et al.
Argentine Patagonia: prevalence and clinical features of multiple sclerosis
Multiple Sclerosis, June 1, 2008; 14(5): 656 - 662.
[Abstract] [PDF]


Home page
Mult SclerHome page
S Bramow, J. Faber-Rod, C Jacobsen, A Kutzelnigg, P Patrikios, P. Sorensen, H Lassmann, and H Laursen
Fatal neurogenic pulmonary edema in a patient with progressive multiple sclerosis
Multiple Sclerosis, June 1, 2008; 14(5): 711 - 715.
[Abstract] [PDF]


Home page
Mult SclerHome page
F Martinelli Boneschi, B Colombo, P Annovazzi, V Martinelli, L Bernasconi, C Solaro, and G Comi
Lifetime and actual prevalence of pain and headache in multiple sclerosis
Multiple Sclerosis, May 1, 2008; 14(4): 514 - 521.
[Abstract] [PDF]


Home page
Mult SclerHome page
D. Galimberti, C. Fenoglio, C. Comi, D. Scalabrini, M. De Riz, M. Leone, E. Venturelli, F. Cortini, M. Piola, F. Monaco, et al.
MDC/CCL22 intrathecal levels in patients with multiple sclerosis
Multiple Sclerosis, May 1, 2008; 14(4): 547 - 549.
[Abstract] [PDF]


Home page
Mult SclerHome page
R. Marignier, J. De Seze, S. Vukusic, F. Durand-Dubief, H. Zephir, P. Vermersch, P. Cabre, G. Cavillon, J. Honnorat, and C. Confavreux
NMO-IgG and Devic's neuromyelitis optica: a French experience
Multiple Sclerosis, May 1, 2008; 14(4): 440 - 445.
[Abstract] [PDF]


Home page
Mult SclerHome page
A. Miller, V. Spada, D. Beerkircher, and R. R. Kreitman
Long-term (up to 22 years), open-label, compassionate-use study of glatiramer acetate in relapsing--remitting multiple sclerosis
Multiple Sclerosis, May 1, 2008; 14(4): 494 - 499.
[Abstract] [PDF]


Home page
Mult SclerHome page
E. Fainardi, R. Rizzo, L. Melchiorri, M. Stignani, M. Castellazzi, C. Tamborino, E. Paolino, M. Tola, E. Granieri, and O. Baricordi
CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing--remitting multiple sclerosis
Multiple Sclerosis, May 1, 2008; 14(4): 446 - 454.
[Abstract] [PDF]


Home page
Mult SclerHome page
M. D Goldman, R. A. Marrie, and J. A Cohen
Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls
Multiple Sclerosis, April 1, 2008; 14(3): 383 - 390.
[Abstract] [PDF]


Home page
Mult SclerHome page
H. Tremlett, Yinshan Zhao, and V. Devonshire
Natural history of secondary-progressive multiple sclerosis
Multiple Sclerosis, April 1, 2008; 14(3): 314 - 324.
[Abstract] [PDF]


Home page
Mult SclerHome page
J. Parratt, R. Tavendale, J. O'Riordan, D. Parratt, and R. Swingler
Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis
Multiple Sclerosis, April 1, 2008; 14(3): 292 - 299.
[Abstract] [PDF]


Home page
BrainHome page
N. L. Sicotte, K. C. Kern, B. S. Giesser, A. Arshanapalli, A. Schultz, M. Montag, H. Wang, and S. Y. Bookheimer
Regional hippocampal atrophy in multiple sclerosis
Brain, April 1, 2008; 131(4): 1134 - 1141.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. L. Minden, D. C. Hoaglin, L. Hadden, D. Frankel, T. Robbins, and J. Perloff
Access to and utilization of neurologists by people with multiple sclerosis
Neurology, March 25, 2008; 70(13_Part_2): 1141 - 1149.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. J. Kragt, A. J. Thompson, X. Montalban, M. Tintore, J. Rio, C. H. Polman, and B.M.J. Uitdehaag
Responsiveness and predictive value of EDSS and MSFC in primary progressive MS
Neurology, March 25, 2008; 70(13_Part_2): 1084 - 1091.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
S. Strasser-Fuchs, C. Enzinger, S. Ropele, M. Wallner, and F. Fazekas
Clinically benign multiple sclerosis despite large T2 lesion load: Can we explain this paradox?
Multiple Sclerosis, March 1, 2008; 14(2): 205 - 211.
[Abstract] [PDF]


Home page
BrainHome page
L. K. Fisniku, P. A. Brex, D. R. Altmann, K. A. Miszkiel, C. E. Benton, R. Lanyon, A. J. Thompson, and D. H. Miller
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
Brain, March 1, 2008; 131(3): 808 - 817.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
R. Zivadinov, A.C. Banas, V. Yella, N. Abdelrahman, B. Weinstock-Guttman, and M.G. Dwyer
Comparison of Three Different Methods for Measurement of Cervical Cord Atrophy in Multiple Sclerosis
AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 319 - 325.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
C. Di Perri, M. Battaglini, M. L. Stromillo, M. L. Bartolozzi, L. Guidi, A. Federico, and N. De Stefano
Voxel-Based Assessment of Differences in Damage and Distribution of White Matter Lesions Between Patients With Primary Progressive and Relapsing-Remitting Multiple Sclerosis
Arch Neurol, February 1, 2008; 65(2): 236 - 243.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. P. D. Henderson, S. A. Trip, P. G. Schlottmann, D. R. Altmann, D. F. Garway-Heath, G. T. Plant, and D. H. Miller
An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography
Brain, January 1, 2008; 131(1): 277 - 287.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
R.A. Marrie and M. Goldman
Validity of performance scales for disability assessment in multiple sclerosis
Multiple Sclerosis, November 1, 2007; 13(9): 1176 - 1182.
[Abstract] [PDF]


Home page
NeurologyHome page
M. G. Brown, S. Kirby, C. Skedgel, J. D. Fisk, T. J. Murray, V. Bhan, and I. S. Sketris
How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
Neurology, October 9, 2007; 69(15): 1498 - 1507.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. Calabrese, N. De Stefano, M. Atzori, V. Bernardi, I. Mattisi, L. Barachino, A. Morra, L. Rinaldi, C. Romualdi, P. Perini, et al.
Detection of Cortical Inflammatory Lesions by Double Inversion Recovery Magnetic Resonance Imaging in Patients With Multiple Sclerosis
Arch Neurol, October 1, 2007; 64(10): 1416 - 1422.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
A.M. Bamer, K. Cetin, D. Amtmann, J.D. Bowen, and K.L. Johnson
Comparing a self report questionnaire with physician assessment for determining multiple sclerosis clinical disease course: a validation study
Multiple Sclerosis, September 1, 2007; 13(8): 1033 - 1037.
[Abstract] [PDF]


Home page
Mult SclerHome page
K. Cetin, K.L. Johnson, D.M. Ehde, C.M. Kuehn, D. Amtmann, and G.H. Kraft
Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample
Multiple Sclerosis, September 1, 2007; 13(8): 1046 - 1053.
[Abstract] [PDF]


Home page
BrainHome page
O. Ciccarelli, C.A. Wheeler-Kingshott, M.A. McLean, M. Cercignani, K. Wimpey, D.H. Miller, and A.J. Thompson
Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis
Brain, August 1, 2007; 130(8): 2220 - 2231.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. Pulizzi, M. Rovaris, E. Judica, M. P. Sormani, V. Martinelli, G. Comi, and M. Filippi
Determinants of Disability in Multiple Sclerosis at Various Disease Stages: A Multiparametric Magnetic Resonance Study
Arch Neurol, August 1, 2007; 64(8): 1163 - 1168.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
F. Agosta, M. Absinta, M. P. Sormani, A. Ghezzi, A. Bertolotto, E. Montanari, G. Comi, and M. Filippi
In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study
Brain, August 1, 2007; 130(8): 2211 - 2219.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. D. Sadovnick, P. Duquette, B. Herrera, I.M.L. Yee, and G. C. Ebers
A timing-of-birth effect on multiple sclerosis clinical phenotype
Neurology, July 3, 2007; 69(1): 60 - 62.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
F. Patti, C. Pozzilli, E. Montanari, A. Pappalardo, L. Piazza, A. Levi, E. Onesti, I. Pesci, and the Italian Study Group on Quality of Life in MS
Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis
Multiple Sclerosis, July 1, 2007; 13(6): 783 - 791.
[Abstract] [PDF]


Home page
Mult SclerHome page
R. H.B. Benedict, J. Bruce, M. G. Dwyer, B. Weinstock-Guttman, C. Tjoa, E. Tavazzi, F. E. Munschauer, and R. Zivadinov
Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis
Multiple Sclerosis, July 1, 2007; 13(6): 722 - 730.
[Abstract] [PDF]


Home page
Mult SclerHome page
M. Ukkonen, X. Wu, B. Reipert, P. Dastidar, and I. Elovaara
Cell surface adhesion molecules and cytokine profiles in primary progressive multiple sclerosis
Multiple Sclerosis, July 1, 2007; 13(6): 701 - 707.
[Abstract] [PDF]


Home page
NEJMHome page
C. Renoux, S. Vukusic, Y. Mikaeloff, G. Edan, M. Clanet, B. Dubois, M. Debouverie, B. Brochet, C. Lebrun-Frenay, J. Pelletier, et al.
Natural History of Multiple Sclerosis with Childhood Onset
N. Engl. J. Med., June 21, 2007; 356(25): 2603 - 2613.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
P. Datta, H.F. Harbo, L.P. Ryder, E. Akesson, J. Benedikz, E.G. Celius, O. Andersen, K.-M. Myhr, M. Sandberg-Wollheim, J. Hillert, et al.
A follow-up study of Nordic multiple sclerosis candidate gene regions
Multiple Sclerosis, June 1, 2007; 13(5): 584 - 589.
[Abstract] [PDF]


Home page
NeurologyHome page
O. Khan
Can clinical outcomes be used to detect neuroprotection in multiple sclerosis?
Neurology, May 29, 2007; 68(22_suppl_3): S64 - S71.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
M. Rovaris, G. Comi, M. Rocca, P. Valsasina, D. Ladkani, E. Pieri, S. Weiss, G. Shifroni, J. Wolinsky, M. Filippi, et al.
Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial
Multiple Sclerosis, May 1, 2007; 13(4): 502 - 508.
[Abstract] [PDF]


Home page
Mult SclerHome page
S.L. Minden, D. Frankel, L. Hadden, and D.C. Hoaglin
Access to health care for people with multiple sclerosis
Multiple Sclerosis, May 1, 2007; 13(4): 547 - 558.
[Abstract] [PDF]


Home page
Neurorehabil Neural RepairHome page
L. Leocani, E. Comi, P. Annovazzi, M. Rovaris, P. Rossi, M. Cursi, M. Comola, V. Martinelli, and G. Comi
Impaired Short-term Motor Learning in Multiple Sclerosis: Evidence From Virtual Reality
Neurorehabil Neural Repair, May 1, 2007; 21(3): 273 - 278.
[Abstract] [PDF]


Home page
Am. J. Neuroradiol.Home page
A.M. Saindane, M. Law, Y. Ge, G. Johnson, J.S. Babb, and R.I. Grossman
Correlation of Diffusion Tensor and Dynamic Perfusion MR Imaging Metrics in Normal-Appearing Corpus Callosum: Support for Primary Hypoperfusion in Multiple Sclerosis
AJNR Am. J. Neuroradiol., April 1, 2007; 28(4): 767 - 772.
[Abstract] [Full Text] [PDF]


Home page
Clin RehabilHome page
M. Giovannelli, G. Borriello, P. Castri, L. Prosperini, and C. Pozzilli
Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis
Clinical Rehabilitation, April 1, 2007; 21(4): 331 - 337.
[Abstract] [PDF]


Home page
Mult SclerHome page
F. Patti, M.P. Amato, M.A. Battaglia, M. Pitaro, P. Russo, C. Solaro, and M. Trojano
Caregiver quality of life in multiple sclerosis: a multicentre Italian study
Multiple Sclerosis, April 1, 2007; 13(3): 412 - 419.
[Abstract] [PDF]


Home page
Mult SclerHome page
P. Sarchielli, M. Zaffaroni, A. Floridi, L. Greco, A. Candeliere, A. Mattioni, S. Tenaglia, M. Di Filippo, and P. Calabresi
Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-{beta} 1a, and high doses of immunoglobulins
Multiple Sclerosis, April 1, 2007; 13(3): 313 - 331.
[Abstract] [PDF]


Home page
Mult SclerHome page
P. Scherer, I.K. Penner, A. Rohr, H. Boldt, I. Ringel, H. Wilke-Burger, E. Burger-Deinerth, K. Isakowitsch, M. Zimmermann, S. Zahrnt, et al.
The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study
Multiple Sclerosis, April 1, 2007; 13(3): 402 - 411.
[Abstract] [PDF]


Home page
Mult SclerHome page
G R Davies, A Hadjiprocopis, D R Altmann, D T Chard, C M Griffin, W Rashid, G J Parker, P S Tofts, R Kapoor, A J Thompson, et al.
Normal-appearing grey and white matter T1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal study
Multiple Sclerosis, March 1, 2007; 13(2): 169 - 177.
[Abstract] [PDF]


Home page
Mult SclerHome page
T E Sherman, L J Rapport, R A Hanks, K A Ryan, P A Keenan, O Khan, and R P Lisak
Predictors of well-being among significant others of persons with multiple sclerosis
Multiple Sclerosis, March 1, 2007; 13(2): 238 - 249.
[Abstract] [PDF]


Home page
Mult SclerHome page
W Rashid, G R Davies, D T Chard, C M Griffin, D R Altmann, A J Thompson, and D H Miller
Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study
Multiple Sclerosis, March 1, 2007; 13(2): 178 - 185.
[Abstract] [PDF]


Home page
NeurologyHome page
D. M. Wingerchuk, S. J. Pittock, C. F. Lucchinetti, V. A. Lennon, and B. G. Weinshenker
A secondary progressive clinical course is uncommon in neuromyelitis optica
Neurology, February 20, 2007; 68(8): 603 - 605.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. J. Pittock
Does benign multiple sclerosis today imply benign multiple sclerosis tomorrow?: Implications for treatment
Neurology, February 13, 2007; 68(7): 480 - 481.
[Full Text] [PDF]


Home page
NeurologyHome page
A.-L. Sayao, V. Devonshire, and H. Tremlett
Longitudinal follow-up of "benign" multiple sclerosis at 20 years
Neurology, February 13, 2007; 68(7): 496 - 500.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
F. Lin, C. Yu, T. Jiang, K. Li, and P. Chan
Diffusion Tensor Tractography-Based Group Mapping of the Pyramidal Tract in Relapsing-Remitting Multiple Sclerosis Patients
AJNR Am. J. Neuroradiol., February 1, 2007; 28(2): 278 - 282.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. E. Hensiek, S. R. Seaman, L. F. Barcellos, A. Oturai, M. Eraksoi, E. Cocco, L. Vecsei, G. Stewart, B. Dubois, J. Bellman-Strobl, et al.
Familial effects on the clinical course of multiple sclerosis
Neurology, January 30, 2007; 68(5): 376 - 383.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Debouverie, C. Lebrun, S. Jeannin, S. Pittion-Vouyovitch, T. Roederer, and H. Vespignani
More severe disability of North Africans vs Europeans with multiple sclerosis in France
Neurology, January 2, 2007; 68(1): 29 - 32.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
B A Parmenter, D R Denney, S G Lynch, L S Middleton, and L M Harlan
Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms
Multiple Sclerosis, January 1, 2007; 13(1): 25 - 32.
[Abstract] [PDF]


Home page
Mult SclerHome page
J M Bruce, D Polen, and P A Arnett
Pain and affective memory biases interact to predict depressive symptoms in multiple sclerosis
Multiple Sclerosis, January 1, 2007; 13(1): 58 - 66.
[Abstract] [PDF]


Home page
Mult SclerHome page
J J Kragt, J M Nielsen, F A. van der Linden, B M. Uitdehaag, and C H Polman
How similar are commonly combined criteria for EDSS progression in multiple sclerosis?
Multiple Sclerosis, November 1, 2006; 12(6): 782 - 786.
[Abstract] [PDF]